From microarrays to genome duplications by Roth, Christian & Hughes, Timothy
Genome Biology 2003, 4:332
c
o
m
m
e
n
t
r
e
v
i
e
w
s
r
e
p
o
r
t
s
d
e
p
o
s
i
t
e
d
 
r
e
s
e
a
r
c
h
i
n
t
e
r
a
c
t
i
o
n
s
i
n
f
o
r
m
a
t
i
o
n
r
e
f
e
r
e
e
d
 
r
e
s
e
a
r
c
h
Meeting report
From microarrays to genome duplications
Christian Roth and Timothy Hughes
Address: Computational Biology Unit, Bergen Centre for Computational Science, University of Bergen, 5020 Bergen, Norway.
Correspondence: Christian Roth. E-mail: chregu@cbu.uib.no
Published: 23 July 2003
Genome Biology 2003, 4:332
The electronic version of this article is the complete one and can be
found online at http://genomebiology.com/2003/4/8/332
© 2003 BioMed Central Ltd 
A report on the fifth annual conference of the Society for
Bioinformatics in the Nordic Countries (SOCBIN),
‘Bioinformatics 2003’, Helsinki, Finland, 22-24 May 2003. 
The annual conference of SOCBIN, held for the first time in
Finland, included talks on protein-structure prediction, gene
regulation and genome evolution. Speakers described experi-
ments and bioinformatic analyses using a wide variety of tech-
niques, such as microarrays, large-scale sequence comparisons,
machine learning and various proteomic techniques. 
Medical and pharmacological genomics
Olli Kallioniemi (University of Turku, Finland) gave the
keynote talk, in which he presented new approaches to over-
coming the existing bottleneck in the process of identifying
suitable research targets (such as drug targets), after candi-
date genes are identified using the fast-growing genomic
and proteomic databases and before high-throughput
screening techniques are used to find drugs themselves.
Two useful techniques are comparative genomic hybridiza-
tion (CGH) and nonsense-mediated RNA decay (NMD)
microarrays, which can both be used to identify genes that
have primary genetic alterations in the condition of interest.
In CGH, genomic DNA from tumor and control tissue is
hybridized to a microarray to identify deletions and inser-
tions (which can cause changes in the copy number of
genes). The relative accumulation of transcripts before and
after inhibition of NMD, measured as a ratio in both cancer
and normal cells, is used to find the genes most likely to
have protein-truncating mutations. A third technique is
cell-based microarrays: arrays in which cDNAs, small inter-
fering RNAs (siRNAs), drugs or other reagents are printed
onto microscope slides and cells are plated on top of the
array. These functional cell-based microarray studies
provide fundamentally different kinds of data from standard
techniques and establish important cause-and-effect rela-
tionships. Finally, sample-based microarray strategies, such
as microarrays of tiny pieces of tumor tissue, facilitate the
analysis of individual DNA, RNA or protein targets in thou-
sands of samples in order to establish definitive clinical cor-
relations for molecular targets at the population level.
In addition to aiding drug-target identification, the new
high-throughput technologies pose novel challenges to prac-
ticing biologists. John Weinstein (National Cancer  Institute,
Bethesda, USA) identified the three most important of these
as statistical analysis, biological interpretation of gene lists
and integration of microarray data with other molecular and
pharmacological information (‘integromics’). As an example,
he mentioned the tests of more than 100,000 chemical com-
pounds on a set of 60 cancer cell lines available from the
National Cancer Institute. This huge amount of data and the
above-mentioned challenges motivated the development of a
number of software tools in Weinstein’s group, including
MedMiner, a tool to organize the biomedical literature on
genes and drugs, and GEEVS (Genomic Exploration and
Visualization System), which integrates multiple types of
molecular information. The whole set of tools is available at
his website [http://discover.nci.nih.gov].
Addressing another key issue in medical research, Ian
Humphery-Smith (University of Utrecht, Netherlands)
explained the importance of the highly efficient mechanisms
in humans that expose developing lymphocytes to the ‘self’
proteome in order to avoid immune reaction against the
body’s own tissues. He presented estimates of the number
within the human proteome of sites made up of five amino
acids within a target peptide, adjacent either in the sequence
or in its structure, which could potentially be targets for an
antibody. He showed that even at 100% identity, the potential
for cross-reactivity between binding proteins was very high,
which works in favor of the body if antibodies cross-react to
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bind to ‘self’ antigens. Exposing developing lymphocytes to
all possible self antigens is difficult not only because of the
high number of epitopes, but also because most proteins in
living cells and body fluids occur at very low abundance and
are consistently clouded by a small number of dominant
species. One solution that the body has found is replication-
induced protein synthesis (RIPS): a small amount of tran-
scription occurs on the open DNA just behind the replication
machinery, leading to the production of tiny amounts of all
proteins contained in the genome. Large numbers of
lymphocytes dying in the thymus and in germinal centers,
and subsequent cross-priming to complement naturally-
occurring endogenously-primed peptides carried by the
major histocompatability complex on antigen presenting
cells, provides the necessary concentrations of physiologi-
cally relevant self elements during lymphocyte development;
cells showing high avidity for self antigens die by apoptosis. 
Protein-structure prediction
Several different approaches to protein-structure prediction
were presented. Christine Orengo (University College
London, UK) presented two protein-structure database
resources: CATH and Gene3D. The CATH database
[http://www.biochem.ucl.ac.uk/bsm/cath/] uses a novel
hierarchical classification of protein domain structures to
cluster proteins at four major levels: class, architecture,
topology and homologous superfamily. Gene3D is a database
of pre-calculated structural assignments for putative pro-
teins encoded within sequenced genomes and was developed
in order to perform comparative analyses of the distribu-
tions of the CATH protein families across the genomes of
different species and kingdoms. Gene3D, which currently
contains information on 66 genomes, has made it possible to
establish that 90% of genes can now be assigned to known
domain families, 60% of which are common to all three
major kingdoms of life.
Moving from structure prediction by homology to ab initio
prediction, Leszek Rychlewski (BioInfoBank Institute,
Poznan, Poland) discussed 3D-Jury, a fully automated con-
sensus protein-structure prediction system (meta-predic-
tor) that is publicly available [http://bioinfo.pl/Meta/]. The
3D-Jury system is similar to other structure meta-predic-
tion servers but it has the highest combined specificity and
sensitivity and shows a high correlation between the
reported confidence score and the accuracy of the model
(as measured by the benchmarking tool LiveBench-6
[http://bioinfo.pl/LiveBench/]). 
Machine learning can be applied to several structure-predic-
tion problems, as described in an overview by Pierre Baldi
(University of California, Irvine, USA). These include predic-
tions of protein secondary structures, the relative solvent
accessibility of residues, the contacts between residues, three-
dimensional protein structures, and inter-chain  sheet
quaternary structures. Several tools relating to these prob-
lems are available at [http://www.igb.uci.edu/tools.htm].
Gene regulation
It is clear from recent work in many labs that regulation of
genes by siRNAs is an important mechanism. When an
siRNA binds to its target mRNA, the mRNA is degraded; this
is called RNA interference (RNAi). Ron Unger (Bar-Ilan
University, Ramat Gan, Israel) presented a method to sys-
tematically scan entire genomes for siRNAs and the genes
they regulate. The method is based on suffix trees, a data
structure that enables a very compact representation of
strings and efficient searching for palindromes. Initial scan-
ning suggests that a large number of genes, about 7% of
Caenorhabditis elegans genes and 3% of C. briggsae genes,
have the potential to be subject to natural RNAi control.
Comparative studies were used to provide evidence that
some of these are real cases of RNAi control; this refinement
leaves about 70 genes that are candidates for verification by
experimental work.
John Mattick (University of Queensland, Brisbane, Australia)
gave an overview of the evidence to suggest that intronic and
other non-coding RNAs comprise a second tier of gene-
expression regulation in the higher eukaryotes, allowing the
integration of complex suites of gene activity. Thus, although
proteins are the fundamental components and effectors of
cellular structure and function, the programming of eukary-
otic complexity and phenotypic variation may be primarily
embedded in an endogenous network of trans-acting RNAs
that relay information on cellular states that is required for
the coordination and modulation of gene expression.
Looking at gene regulation more generally, Daphne Koller
(Stanford University, USA) described an automated proba-
bilistic framework for discovering regulatory modules from
gene-expression data. The method simultaneously searches
for groups of genes that fit into modules (groups of coregu-
lated genes) and for a regulation program for each module
that explains the expression behavior of genes in the module
as a function of the activity of some set of regulators. The
method has been applied to a yeast gene-expression dataset,
and the results have been validated using gene annotations,
known regulatory relationships, and known and novel
binding-site motifs, demonstrating the method’s ability to
identify highly coherent modules and their regulators.
Gene regulation can be affected by polymorphisms. Yitzhak
Pilpel (Weizmann Institute of Science, Rehovot, Israel) pre-
sented novel data-mining techniques (assembled in the
web application rMotif [http://bioportal.weizmann.ac.il/
~lapidotm/rMotif/html/]) that make it possible to predict
the effect of regulatory single-nucleotide polymorphisms
(rSNPs), through the analysis of sequences, expression data
and structural data. The main use of the application is in
Genome Biology 2003, 4:332prioritizing rSNPs according to their ability to appreciably
affect gene-expression profiles.
Comparative genomics
The growing amount of available genomic data, especially
complete genome sequences, has made comparative
genomics an expanding field in bioinformatics. Kenneth
Wolfe (Trinity College Dublin, Ireland) compared the com-
plete genomes of the yeast Saccharomyces cerevisiae and
the plant Arabidopsis thaliana. These genomes contain
large regions where a series of genes on one chromosome
has a series of paralogs on another chromosome, with con-
served gene order. In both S. cerevisiae and  A. thaliana,
almost the entire genome can be paired in this way, which
suggests that polyploidization (duplication of the whole
genome), rather than duplication of smaller parts of chro-
mosomes, has occurred. In Arabidopsis, polyploidization
events are estimated to have occurred 24-40 and 92 million
years ago. Only a few genes are retained as duplicates and
the rest are deleted soon after polyploidization. Current
investigation in Wolfe’s group focuses on the factors deter-
mining which genes are retained in duplicate.
Evan Eichler (Case Western Reserve University, Cleveland,
USA) compared duplicated segments in the human and
rodent genomes. The duplicated regions in the human
genome are highly non-random and show a high level of
nucleotide identity (>95%) spanning large genomic dis-
tances (1-100 kb). Through processes of non-allelic homolo-
gous recombination, these regions provide a significant
source of genetic disease in the human population. Analysis
of other vertebrate genomes indicates that the high amount
of segmental duplication might be a relatively unusual prop-
erty of our genome: the mouse genome, for example, has
fewer duplications, and these are mostly intrachromosomal.
These duplications in the human genome have an impact on
the assembly of draft genome sequences, as duplicated seg-
ments can be mistaken for versions of the same sequences.
Comparative genomics can also be used to study one of the
traditional explanations for eukaryotic phenotypic complex-
ity - alternative splicing. Christopher Lee (University of Cali-
fornia, Los Angeles, USA) reported an analysis of 9,434
orthologous genes in human and mouse that indicates that,
whereas most exons in the mouse and human genomes are
strongly conserved in both genomes, exons that are included
only in alternative splice forms (as opposed to the major
transcript form) are mostly not conserved, and thus are the
product of recent exon creation/loss events.
Diving into one of the most topical controversies, Dan Graur
(Tel Aviv University, Israel) presented an analysis of the
functional role of junk DNA in the human genome, focusing
on Alu repetitive elements and nuclear sequences of mito-
chondrial origin (‘numts’). Alu elements in introns can be
converted into new exons by changes in splicing. He revealed
that there are only a few alternatively spliced exonized Alu
elements in the human genome and that there is strong nega-
tive selection on constitutively spliced Alu elements favoring
the loss of the element. The analysis of the numts showed
that there have been only a few actual independent insertions
of these sequences into the genome and many post-inser-
tional duplications. In addition, all the numts seem to be
devoid of function. He concluded that nonfunctional DNA
cannot be easily recruited into new functions.
The sequences that do not match sequences in other
genomes are also being studied. Marie Skovgaard (Technical
University of Denmark, Lyngby, Denmark) has found that
the genome of Methanopyrus kandleri AV19, like many
other newly sequenced prokaryotic genomes, contains large
numbers - up to 30% - of orphan protein-coding genes, that
is, genes with no homology to known genes in any other
species. Instead of being randomly scattered throughout the
genome as in other species, however, a large fraction of these
genes occurs within two large regions of the genome.
Although they show no homology to known genes except
within  M. kandleri, neither their length nor their codon
usage gives any reason to suspect that they are random (arti-
factual) open reading frames. These regions could be consid-
ered as candidates for massive lateral transfer, but the
bioinformatic analysis suggests that they have evolved by
vertical descent.
Two speakers presented new tools related to sequence align-
ments. A hidden Markov model (HMM) is a computational
structure for describing the subtle patterns that define fami-
lies of homologous sequences; such models are powerful
tools for detecting distant relatives. More specifically,
HMMs are probabilistic models composed of interconnected
states, in this case whether a site in two different sequences
is a match or not, or whether there has been a deletion or an
insertion. Transition probabilities are associated with the
connections between the states, and residue emission proba-
bilities are associated with the match and insert states.
Markus Wistrand (Karolinska Institute, Stockholm, Sweden)
showed how the method of estimation of transition priors
(model initialization values that make sure that overfitting of
models is avoided) as well as structural information and neg-
ative sequences can help fine tune HMMs by improving the
estimation of transition probabilities. The ideas have been
tested using the program HMMER and a benchmarking test
that is based on detection of remotely related sequences
hidden among unrelated sequences. Compared with the
default version of HMMER, these improvements decreased
the number of false predictions by roughly 10%. 
Finally, Robert Giegerich (Bielefeld University, Germany) pre-
sented a generalization of an alignment of sequences in terms
of tree structures and forests (collections of tree structures):
an alignment is considered as a data structure, not an editing
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Genome Biology 2003, 4:332process (a sequence of deletions, insertions and matches),
and it is not to be confused with the matrix form that is used
as a visualization of the alignment. This generalization is
used in RNA-forester [http://bibiserv.techfak.uni-bielefeld.de/
bibi/Tools_RNA_Studio.html], an alignment tool for RNA
secondary structures that is suitable for global comparison
of RNA secondary structures and for finding similar regions
between them. 
It is clear from this conference that bioinformatics, together
with new experimental technologies, is giving a lot of insight
into many biological systems.
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